NHIV SEC filings, in plain English
Everything NewHold Investment IV has filed with the SEC that we hold — 34 filings, newest first, 31 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Quarterly report on Form 10-Q for NewHold Investment Corp IV, a blank-check SPAC in its pre-business-combination phase. This is the company's first 10-Q since its IPO on April 16, 2026, which closed at $201.25 million. The trust now holds $202.7 million equating to $10.06 per share. The company reported net income of $854,000 for Q2 and $816,000 YTD, primarily from trust interest income. The CFO resigned in July 2026 and was replaced. Why it matters: The filing confirms the trust is fully funded at $10.06 per share, slightly above the $10.00 IPO proceeds. The company has until April 16, 2028 to complete a business combination. The CFO change and $250,000 working capital withdrawal from the trust in August 2026 are updates on sponsor conduct and cash management. No target has been identified.
What changed vs 2026-05-29trust $201.3M → $202.7M +1%trust account, combination deadline, redeemable shares1 moved · 2 with no prior record of ours
- Trust account
- $201.3M$202.7M
- Combination deadline
- not previously extracted2028-04-16
- Redeemable shares
- not previously extracted20.1M
SpacBrain reads this as $1,465,000 was added to the trust between the two filings.
The clause …“offering costs — 83,000 Total current assets 1,598,000 91,000 Investments held in Trust Account 202,715,000 — Total Assets $ 204,313,000 $ 91,000 Liabilities and Shareholders’ Deficit Current liabilities Accounts payable $ 1,000 $”…
The clause …“and (y) the distribution of the Trust Account, as described below. We have until April 16, 2028 (24 months from the closing of the Initial Public Offering), or until such (x) earlier date as our board of directors may approve or”…
The clause …“to accumulated deficit. Accordingly, as of June 30, 2026, all of the 20,125,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: This document is an Exhibit 99.1 Joint Filing Agreement pursuant to Rule 13d-1(k) appended to a Schedule 13G filing, in which the undersigned entities and individuals—LMR Partners LLP, LMR PARTNERS Ltd, LMR Partners LLC, LMR Partners AG, LMR PARTNERS (DIFC) Ltd, LMR Partners (Ireland) Limited, Ben Levine, and Stefan Renold—acknowledge that the initial statement is filed on their collective behalf and establish that future amendments will be submitted jointly without executing additional agreements unless separately mandated by law. The attached text contains only procedural acknowledgments, liability disclaimers regarding information accuracy, and execution blocks dated 08/14/2026, signed by Shane Cullinane (Chief Operating Officer), Allyson Hanlon (Deputy General Counsel), Ben Levine, and Stefan Renold. It discloses no adjustments to beneficial ownership percentages, share quantities, acquisition costs, investment purposes, or any modifications to NHIV’s SPAC operating parameters, including its search phase status, per-share trust balance, combination deadline, extension procedures, target negotiation stage, or sponsor management conduct. Why it matters: While the agreement formally consolidates regulatory reporting obligations for the listed LMR Partners affiliates and associated persons, the excerpt provides no actual holding tables, voting power thresholds, or statements of control intent. Investors tracking the NHIV redemption calendar, trust account trajectory, merger development pace, or leadership accountability will find no operative updates or conduct revelations in this administrative attachment, which solely creates a unified amendment filing pathway for the group subject to applicable statutory requirements.
What changed: A Joint Filing Agreement pursuant to SEC Rule 13d-1(k) attached to a Schedule 13G, executed on August 14, 2026, by NewHold Industrial Technology IV, LLC, Kevin Charlton, and Samy Hammad to coordinate beneficial ownership reporting. This filing introduces no changes to NHIV’s redemption mechanics, trust value ($10.06 per share), business combination deadline (2028-04-16), deal progress, or sponsor conduct. The text contains only standard regulatory boilerplate confirming that Charlton and Hammad accept joint filing responsibility, will bear individual accountability for the accuracy of their respective reported information, and agree that all future Schedule 13G amendments will be submitted collectively. The document makes no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: For shareholders monitoring the search timeline and trust dynamics, this filing confirms the continued compliance posture of the named reporting persons and preserves a single, consolidated avenue for future ownership disclosures through the 2028-04-16 deadline. While it adds no incremental data on target selection, acquisition timelines, or potential redemptions, it verifies that the sponsoring team remains structurally intact and actively engaged with SEC reporting obligations. Investors should note that the absence of operational updates in routine ownership reports is expected during an active search phase.
What changed: A Schedule 13G beneficial ownership report listing AQR Capital Management, LLC; AQR Capital Management Holdings, LLC; and AQR Arbitrage, LLC as security holders. The filing discloses that these three AQR entities hold beneficial ownership in NHIV. The provided excerpt contains no share quantities, percentage thresholds, acquisition or disposition dates, amendment markers, or statements addressing redemption behavior, trust administration, extension requests, target acquisition progress, or sponsor conduct. No ownership shift or corporate action is detailed in the text. Why it matters: Investors tracking NHIV should recognize that while the report establishes institutional shareholder presence, the omission of quantity disclosures, purpose-of-transaction language, and voting or put/call agreements means the filing carries no immediate implications for redemption liquidity, trust preservation, or expiration pacing. Because the AQR entities themselves assert the holding position and provide no strategic rationale or activism signals, the document neither pressures the SPAC toward a business combination timeline nor alters valuation trajectories. No financial, operational, or contractual terms appear in the excerpt.
What changed: A routine compliance exhibit—specifically, a Joint Filing Agreement attached to a Schedule 13G beneficial ownership report, executed pursuant to Rule 13d-1(k). Regarding redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, this filing introduces no changes. It contains no language modifying the redemption window, the per-share trust balance, any proposed business combination timeline, extension voting mechanics, or sponsor governance standards. The only operational update is administrative: it formalizes that Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross will submit future Schedule 13G amendments jointly, with each party bearing independent responsibility for the completeness and accuracy of their own disclosures, and liability for third-party inaccuracies limited to instances where they know or have reason to believe the information is false. The agreement is dated August 12, 2026. Why it matters: No substantive business, financial, or strategic claims appear in this document. There are no statements regarding customers, revenue streams, market sizing, investment strategy, proprietary technology, commercial partnerships, litigation exposure, or personnel movements. Because no executives, sponsors, or target company representatives are cited, and because the text exclusively governs SEC reporting logistics among affiliated holders, there are no attributable forward-looking assertions or operational disclosures. Consequently, this filing does not alter NHIV’s search-phase trajectory, trust preservation obligations, or de-SPAC structural timeline. Investors monitoring the redemption calendar, extension thresholds, or sponsor alignment should treat this as a procedural administrative record with zero economic or mechanical impact on the SPAC vehicle.
What changed: A Form 8-K current report documenting the resignation of Chief Financial Officer Polly Schneck and the Board's simultaneous appointment of John Boone as her successor. On July 22, 2026, Polly Schneck gave written notice of her resignation as CFO, effective immediately, stating per the filing that she departs to pursue other professional opportunities and that the Board confirmed no disagreements with management or corporate policy. The Board immediately appointed John Boone as CFO effective the same date. Kevin Charlton continues serving as Chief Executive Officer. The filing discloses that Mr. Boone's compensation arrangements have not yet been finalized and will be reported when determined. Why it matters: The executive transition shifts financial leadership during the SPAC’s search window (deadline 2028-04-16). The Board’s swift appointment of a replacement with documented experience across public equity, private equity, and restructuring investment banking signals an orderly handover rather than operational distress. However, the unfinalized compensation package for Mr. Boone leaves potential executive expense variables open until disclosed. Redemption mechanics remain untouched: the trust maintains $10.06 per share, no extension has been proposed, and no business combination or target engagement is referenced in this filing.
What changed: Amendment No. 1 to NewHold Investment Corp IV's Form 10-Q for the quarter ended March 31, 2026, filed July 21, 2026 and stated to be solely to correct typographical errors. The pre-IPO shell reported total assets of $281,000, total current liabilities of $341,000, accumulated deficit widening from $47,000 to $85,000, and $86,000 drawn against a sponsor promissory note capped at $350,000. Note 8 discloses the April 16, 2026 IPO of 20,125,000 units at $10.00 with the over-allotment exercised in full, and $201,250,000 placed in trust with Continental Stock Transfer & Trust. Why it matters: The Liquidity note still carries a stray drafting comment mid-sentence - 'should document that subsequent to 3/31 the IPO alleviated substantial doubt' - inside an amendment whose only stated purpose was fixing typographical errors, so the cleanup was incomplete. Substantively the figures that matter are post-quarter: $201,250,000 in trust against 20,125,000 public shares is $10.00 per share, and $7,043,750 of deferred underwriting discount sits ahead of shareholders at any closing. Sponsor and BTIG bought 641,250 private placement units at $10.00.
What changed: Quarterly report on Form 10-Q for the period ended March 31, 2026, filed by blank check company NewHold Investment Corp IV. The 10-Q covers the pre-IPO quarter ended March 31, 2026. Key subsequent event: On April 16, 2026, NHIV consummated its IPO of 20,125,000 units at $10.00/unit (including full exercise of the over-allotment option), generating gross proceeds of $201,250,000. Simultaneously, it completed a private placement of 641,250 units to the Sponsor and BTIG, LLC at $10.00/unit. Total of $201,250,000 was placed into trust ($10.00 per public share). The trust was funded as of April 16, 2026. At March 31, 2026, the company had no cash, deferred offering costs of $277,000, and an accumulated deficit of $85,000. It reported a net loss of $38,000 for the quarter. No Class A shares were outstanding at period end; only 6,708,333 Class B founder shares were outstanding (up to 875,000 subject to forfeiture). The underwriters' deferred discount is $7,043,750. The completion window is 24 months from the IPO close (i.e., by April 16, 2028). Why it matters: This filing confirms the SPAC is fully funded post-quarter, with $201.25M in trust ($10.06 per share, including deferred underwriting commissions). The deadline to complete a business combination is April 16, 2028. No target has been identified or discussions initiated as of the filing date; the company is in the active search phase. The filing establishes the baseline trust value, unit structure (one share plus 1/3 warrant), warrant exercise price of $11.50, and standard sponsor lock-up and redemption mechanics.
What changed: A Form 8-K current report and attached audited balance sheet announcing the consummation of NewHold Investment Corp IV’s initial public offering. The registrant reports that its IPO closed on April 16, 2026, selling 20,125,000 units at $10.00 per unit, generating $201,250,000 in gross proceeds. The filing confirms that $201,250,000 was placed in a U.S.-based trust account with Continental Stock Transfer & Trust Company acting as trustee. The company’s amended and restated memorandum and articles establish a 24-month Completion Window from the April 16, 2026 closing, meaning redemption or liquidation if no business combination occurs by April 16, 2028. The filing details a simultaneous private placement of 641,250 units to Sponsor NewHold Industrial Technology IV LLC and underwriter BTIG, LLC at $10.00 per unit. Deferred underwriting commissions of $7,043,750 are payable only upon business combination completion. The Sponsor previously purchased 6,708,333 founder shares in October 2025 for $25,000. Executive officers receive $15,000 per month in deferred compensation payable upon business combination consummation, alongside a $50,000 monthly administrative services agreement with an affiliate, Valence Management LLC. Why it matters: This filing locks the trust account at exactly $201,250,000 (the filing notes an assumed redemption price of approximately $10.00 per public share), establishing the precise cash floor for future redemptions. It confirms the absolute liquidation deadline of April 16, 2028, with no automatic extension mechanism disclosed beyond board-approved earlier dates. The 80% net trust fair market value target threshold and the alignment of executive pay with successful deal completion are standard SPAC mechanics. Public shareholders retain full redemption rights at trust proportionality (plus interest less taxes), while the Sponsor, officers, and directors have explicitly waived redemption rights on their founder and private shares and contractually pledged to vote any founder shares held in favor of the initial business combination. The registrant states that as of the filing date, it has not selected a specific business combination target and has engaged in no substantive discussions with any prospective target, meaning investor capital remains idle in the trust account awaiting deployment over the remaining ~24 months.
What changed: SEC Form 3 — Initial Statement of Beneficial Ownership. Per the April 22, 2026 filing submitted by Director James Yerbic, zero non-derivative transactions or holdings were reported. This leaves NHIV’s searching status, $10.06 trust/share balance, and April 16, 2028 redemption deadline completely unaltered. No extension votes, redemption window shifts, or sponsor capital adjustments occur. Why it matters: For investors monitoring redemption mechanics and sponsor conduct, the filing establishes a verified baseline of no insider accumulation or reduction. In a SEARCHING vehicle, this negative report eliminates near-term signaling noise regarding deal progression or liquidity pressure, while preserving the existing cash runway and deadline architecture. No claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel accompany the submission.
What changed: Routine compliance exhibit — SEC Form 3 initial ownership report. In its own terms, this document IS a routine compliance exhibit — an SEC Form 3 initial ownership report. Regarding the specified mechanics, the filing records no activity that would adjust the trust value of $10.06 per share, the 2028-04-16 liquidation deadline, any extension timeline, target deal progress, or sponsor conduct. As a further matter of substance, the filing explicitly states that the named reporting person Hammad Samy (President and COO) made no equity-related submissions, noting there are 'No non-derivative transactions or holdings reported.' The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or additional personnel movements. Why it matters: For investors tracking NHIV’s redemption calendar and search-phase dynamics, this Form 3 establishes a neutral administrative baseline. It does not modify the trust account, shift the redemption deadline, signal enhanced sponsorship alignment, or indicate business combination pursuit. The stated absence of reported holdings reflects standard initial reporting protocol for an insider with no disclosed public equity position, leaving redemption thresholds, extension risk, and capital deployment timelines unchanged.
What changed: Form 3 initial statement of beneficial ownership. Director Charlie Baynes-Reid reported zero non-derivative transactions and no holding adjustments, leaving insider equity exposure completely unchanged. Why it matters: This routine compliance submission confirms no shift in board alignment or derivative-triggering events that could influence sponsor conduct or voting behavior ahead of a proposed merger. The filing contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or additional personnel movements. Consequently, the company’s searching status, per-share trust value, and conversion deadline remain unaltered by this document.
What changed: A Form 3 initial insider ownership report under Section 16(a) of the Securities Exchange Act of 1934, identifying NewHold Investment Corp IV as the issuer and director Scott Scharfman as the reporting person. The filing expressly states “[n]o non-derivative transactions or holdings reported,” confirming that the named director carries no recorded equity positions or derivative contracts at the time of submission. Why it matters: For NHIV investors tracking redemption deadlines, trust valuation, extension triggers, and sponsor conduct, this routine compliance exhibit introduces no alteration to any of those mechanics. The explicit absence of reported insider transactions or balances yields no actionable data regarding management’s confidence in a prospective target, voting posture ahead of the liquidation window, or capital-alignment signals. Outside of standard regulatory disclosures, the document contains zero claims regarding customer metrics, revenue streams, total addressable market, strategic pivots, proprietary technology, commercial partnerships, ongoing litigation, or executive appointments. As a null transaction report, it functions purely as a statutory receipt confirming that no insider equity adjustments triggered SEC disclosure requirements during the reporting period.
What changed: An 8-K Current Report filed by NewHold Investment Corp IV upon the consummation of its initial public offering, detailing the IPO closing, entry into material definitive agreements, unregistered sales of equity securities, and charter amendments. The SPAC completed its IPO of 20,125,000 units at $10.00 per unit, including full exercise of the over-allotment option, generating gross proceeds of $201,250,000. Simultaneously, it completed private placements of 641,250 units (440,000 to Sponsor, 201,250 to BTIG) at $10.00 per unit. Total trust deposit: $201,250,000. The company filed its amended and restated memorandum and articles of association and entered into underwriting, warrant, trust, registration rights, private placement, letter, administrative services, and indemnity agreements. Why it matters: This filing establishes the SPAC's capital structure, trust account ($10.00 per share), and a 24-month deadline to complete a business combination (April 16, 2028). It details sponsor economics, lock-up provisions, and insider commitments to vote for and not redeem shares in a business combination. Investors can now track the trust value, deadlines, and sponsor conduct as the SPAC searches for a target.
What changed: 424B4 prospectus for the initial public offering of NewHold Investment Corp IV, a blank check company formed to effect a merger or acquisition, filed pursuant to Rule 424(b)(4). This is the IPO prospectus filed upon effectiveness of the registration statement. It sets the terms of the offering: 17,500,000 units at $10.00 per unit (each unit consists of one Class A ordinary share and one-third of one redeemable warrant). The trust will hold $175,000,000 ($10.00 per unit). The SPAC has 24 months from closing (estimated April 2028) to complete a business combination. No target has been selected; no substantive discussions initiated. The sponsor and BTIG have committed to purchase 588,750 private units at $10.00 per unit. Non-managing sponsor investors have expressed interest in purchasing up to approximately 7,000,000 units in the offering and 300,000 private units. The founder shares (6,708,333 Class B shares) were issued to sponsor for $25,000. Trust proceeds will be invested in U.S. government obligations or money market funds. Redemption rights: public shareholders may redeem shares upon completion of business combination at per-share price equal to trust amount (including interest) less taxes and working capital withdrawals (not to exceed $250,000 annually). Deadline for business combination is 24 months from closing, extendable by shareholder vote with additional redemption rights. If no business combination, trust will be liquidated and public shares redeemed. No material change in SPAC status (still searching); this is the IPO prospectus itself. Why it matters: This is the definitive IPO prospectus for NHIV, establishing the trust value ($10.00 per unit), deadline (24 months from closing), redemption mechanics, and sponsor economics. It provides the baseline for all future investor decisions regarding redemptions, extensions, and business combination votes. The document also details the substantial dilution public shareholders will face (sponsor founder shares at $0.004 per share vs. $10.00 offering price) and the significant conflicts of interest inherent in the sponsor's incentive structure. The inclusion of non-managing sponsor investors with expressions of interest in up to 7,000,000 units (34.78% of the offering) and their indirect ownership of founder shares through the sponsor is a notable structural feature.
What changed: A routine SEC Form 3 compliance exhibit—an initial statement of beneficial ownership. Reporting person Isobel Paola Schneck (Chief Financial Officer) recorded no non-derivative transactions and reported no holdings, leaving insider positions, the trust account, the business combination deadline, and all redemption mechanics entirely unchanged. Why it matters: Shareholders tracking redemption windows, extension votes, target pursuit, or sponsor conduct receive no timeline or structural updates. This filing is purely administrative, confirming baseline insider status without affecting shareholder redemption rights, trust preservation rules, or deal progression.
What changed: A Form 3 routine compliance exhibit disclosing initial or updated insider beneficial ownership. In its own terms, this is an insider ownership report filed by director Thomas J. Sullivan. The filing explicitly states 'No non-derivative transactions or holdings reported,' confirming no change to insider positions, which leaves the SPAC’s redemption deadline of 2028-04-16, the trust value of $10.06 per share, and the search-phase timeline entirely unchanged. Beyond mechanics, the document contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; according to the filing itself, nothing beyond the baseline ownership status is reported or attributed to any executive or sponsor representative. Why it matters: For investors tracking NHIV, routine empty Form 3 filings verify that directors have not engaged in undisclosed accumulation or distribution, preserving clear baselines for measuring future sponsor alignment ahead of potential extension votes, redemption windows, or business combination announcements. This transparency prevents speculation over quiet insider positioning during the Searching phase and ensures that any subsequent capital calls, tender offers, or voting behavior can be accurately benchmarked against a confirmed starting position.
What changed: SEC Form 3 – Statement of Beneficial Ownership of Securities (a routine compliance exhibit). This filing confirms that on 2026-04-16, NewHold Industrial Technology IV, LLC (designated a 10% owner) reported no non-derivative transactions or holdings adjustments. The document does not modify the redemption deadline of 2028-04-16, change the trust value of $10.06 per share, introduce extension provisions, indicate merger or deal progress, or reflect alterations in sponsor conduct beyond the static confirmation of unchanged affiliate positions. Why it matters: For a SPAC in SEARCHING status, a zero-activity Form 3 locks in a dated snapshot of sponsor alignment prior to the capital raise sunset. Because the filing attributes no movement to the 10% stake held by NewHold Industrial Technology IV, LLC on 2026-04-16, investors can anchor their analysis of potential redemption drag and extension voting power against the standing $10.06 trust share value without adjusting for recent insider accumulation or dilution. The submission contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The absence of positional shifts indicates the sponsor has not altered its economic or voting leverage, leaving timeline and deal-prospect risk entirely dependent on subsequent corporate disclosures and shareholder redemption behavior.
What changed: SEC Form 3 initial statement of beneficial ownership filed by NewHold Investment Corp IV director Sezaneh Taherian to register insider equity positions under Section 16(a) of the Securities Exchange Act. As explicitly certified by the reporting person on the filing, there were "No non-derivative transactions or holdings reported" for the applicable period. Consequently, no director shares were purchased, sold, or pledged; no options, warrants, or convertible notes were issued, exercised, or canceled; and no ownership concentration shifted that would modify sponsor governance leverage, extension negotiation stance, or redemption pressure relative to the stated 2028-04-16 expiration. Why it matters: Although the submission contains no operational disclosures, target pipeline details, customer acquisition claims, revenue forecasts, market sizing, strategic roadmaps, technology validations, partnership architectures, litigation docket updates, or broader personnel movements beyond the singular director entry, its procedural clarity confirms a flat insider ledger. For capital providers monitoring distribution timing, trust preservation mechanics, and sponsor execution discipline, verifying the absence of unreported executive liquidation or concentrated accumulation eliminates speculative drift around insider flight risk, allowing shareholders to anchor redemption scheduling and capital allocation models strictly on the published calendar deadline and prevailing secondary market liquidity rather than unannounced executive positioning.
What changed: SEC Form 3 (Initial Statement of Beneficial Ownership of Securities), a routine compliance exhibit used to publicly record an insider’s initial or ongoing equity position in a listed issuer. Filed for NewHold Investment Corp IV, the submission names director Phil Horlock as the reporting person and explicitly states 'No non-derivative transactions or holdings reported.' This confirms that insider equity levels remained static during the reporting window, introducing no new data points that would impact shareholder redemption calculations, trust account valuations, potential timeline extensions, business combination search milestones, or sponsor conduct metrics. Why it matters: The filing’s singular substantive assertion—that the director holds zero reported non-derivative movements—is attributed directly to the Form 3 submission itself, not to external commentary or executive testimony. Because the document contains no statements, projections, or disclosures regarding customer acquisition, revenue generation, total addressable market estimates, corporate strategy, proprietary technology, strategic partnerships, regulatory or civil litigation, or executive appointments and departures, it offers no forward-looking guidance. For investors tracking NHIV, this routine compliance filing serves strictly as a neutral baseline confirming unchanged insider positioning, preserving the existing capital structure without accelerating deal timelines or triggering governance reviews, while leaving the remaining operational and financial variables to future periodic disclosures.
What changed: SEC Form 3 insider ownership report for NewHold Investment Corp IV, filed by Chief Executive Officer Kevin M. Charlton on 2026-04-15. Per the filing, the chief executive disclosed no non-derivative transactions or holdings. The document contains no share counts, dollar amounts, or derivative positions, and reports no change in insider equity or sponsor trading activity. Why it matters: The submission functions as a routine Section 16 compliance record. Because the chief executive reported zero stock movements and the text contains no numerical disclosures, it offers no new signals regarding deal search progress, extension timing, trust preservation, or sponsor conduct. It makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or other personnel updates. The mechanical and operational baseline tracked by investors remains unaltered by this filing.
What changed: SEC Form 3 insider ownership report (routine compliance exhibit). Director Brian Mathis filed the Form 3 with the explicit disclosure that there are “No non-derivative transactions or holdings reported,” leaving NHIV’s operational status, $10.06 trust value per share, and April 16, 2028 deadline entirely unchanged. Why it matters: The filing bears on no redemption mechanics, trust accounting, extension procedures, acquisition timeline, or sponsor governance. The filer attributed the zero-disclosure statement directly to Mathis, confirming it is an administrative record of initial registration rather than a signal of position building or strategic shift. Because it contains no claims about customers, revenue, market size, technology, partnerships, litigation, or personnel, it provides no new investor-relevant data despite its procedural filing date one day before the SPAC’s anniversary window.
What changed: A Form 3 filing, explicitly labeled in the text as an 'insider ownership report' for issuer NewHold Investment Corp IV, submitted by director Mikula Bryan under accession number 0001213900-26-044273. The filing states verbatim that there were 'No non-derivative transactions or holdings reported.' Consequently, there is no update to director share count, no movement in trust account composition, and no indication of shifted sponsor conduct or deal-stage signaling relative to the SPAC’s ongoing search phase. Why it matters: For investors calibrating redemption expectations, extension probabilities, or acquisition timeline estimates, this submission confirms a flat insider footprint. With zero reported purchases or disposals by the director, the filing provides no new signal to adjust redemption forecasts, anticipate an amendment vote, or reassess sponsor alignment. It merely establishes a baseline of zero ownership activity during the capital-raising and target-sourcing window, leaving the liquidation clock and trust metrics untouched.
What changed: A Form 8-A for Registration of Certain Classes of Securities Pursuant to Section 12(b) of the Securities Exchange Act of 1934, which functions as a routine compliance listing registration rather than a merger agreement, resignation, interview transcript, investor presentation, or lawsuit. According to the registrant, the filing formally registers for Nasdaq trading: units composed of one Class A ordinary share ($0.0001 par value) and one-third of one redeemable warrant; standalone Class A ordinary shares ($0.0001 par value); and whole redeemable warrants exercisable at an exercise price of $11.50. The registrant states these security descriptions incorporate by reference the Form S-1 Registration Statement (No. 333-293559) originally filed February 18, 2026. As executed, it amends none of the SPAC’s redemption deadline, trust account valuations, extension mechanisms, or active target search. Why it matters: As characterized by the registrant, this routine registration establishes the secondary-market plumbing for NHIV’s units, shares, and warrants but introduces no adjustments to the combination timeline, per-share trust accounting, or sponsor governance. All mechanical parameters—the $11.50 warrant strike, the $0.0001 par value, the one-third warrant ratio, and the reliance on the February 18, 2026 S-1 disclosures—are stated directly by the company. The filing was authorized on April 14, 2026, by Chief Executive Officer Kevin Charlton. Beyond standard securities law requirements and corporate execution, the registrant provides no claims concerning prospective target customers, operating revenue, addressable market size, proprietary technology, strategic partnerships, material litigation, or executive compensation shifts.
What changed: A Rule 461 correspondence submitting an acceleration request for a Form S-1 registration statement. NewHold Investment Corp IV, through Paul Wood, Managing Director of BTIG, LLC, requests that the SEC accelerate the Form S-1 effective date to 4:00 p.m. ET on Tuesday, April 14, 2026, following an initial filing on February 18, 2026 (File No. 333-293559). The submission confirms distribution of preliminary prospectus copies to reasonably anticipated underwriters and dealers, and asserts ongoing compliance with Exchange Act Rule 15c2-8. Why it matters: This advances the registration-to-pricing timeline, indicating preparation to collect capital ahead of any subsequent combination search or extension considerations. It does not alter the April 16, 2028 redemption deadline, the $10.06 per share trust account balance, or any existing deal progress or sponsor conduct parameters you track. Aside from routine administrative routing to legal counsel Loeb & Loeb LLP, the filing discloses no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. All procedural assertions and the acceleration request originate solely from BTIG, LLC’s authorized signatory and the registrant’s filing team.
What changed: A corporate correspondence (CORRESP) filed with the SEC’s Division of Corporation Finance, specifically a Rule 461 request submitted by Chief Executive Officer Kevin Charlton to accelerate the effectiveness of NewHold Investment Corp IV’s Registration Statement on Form S-1 (File No. 333-293559) to 4:00 p.m. on April 14, 2026. No structural terms, redemption calendars, trust account provisions, extension votes, or target acquisition timelines were amended. The filing contains no modifications to how shareholders would receive distributions, no adjustments to the stated business combination deadline, and no evidence of sponsor trading or governance changes beyond the standard registration acceleration. Why it matters: This is an administrative step required to proceed toward an initial public offering. Chief Executive Officer Kevin Charlton’s submission contains no claims regarding customers, projected revenue, total addressable market, merger strategy, technology, partnerships, pending litigation, or executive compensation. Because the correspondence is purely procedural, it signals continued listing preparation but delivers zero actionable intelligence on deal progress, shareholder vote mechanics, or trust value allocation.
What changed: Amendment No. 2 to Form S-1 registration statement (Registration No. 333-293559) containing a preliminary prospectus, dated March 25, 2026, for NewHold Investment Corp IV's initial public offering of 17,500,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one-third of one warrant, with BTIG as sole book-running manager. The company is a Cayman Islands blank check company still in registration; no business combination target has been selected and no substantive target discussions have been initiated. The filing does not recite a change log, so the specific delta from Amendment No. 1 is not identifiable from this text. What is present is the full updated IPO prospectus: $175,000,000 of offering proceeds plus private-unit proceeds to be deposited into a U.S. trust account ($201,250,000 if the over-allotment option is exercised in full), trust initially $10.00 per public share; 24-month period from the offering closing to complete an initial business combination, extendable by shareholder approval with no stated limit on number or length of extensions, although the company says it does not expect to need to extend beyond 36 months; redemption rights at deal closing at trust value per share, with a 15% per-beneficial-holder redemption cap if shareholder approval is used; full liquidation redemption at trust value if no deal is completed within the completion window; no maximum redemption threshold; sponsor purchase of 6,708,333 founder shares for $25,000, sponsor/BTIG purchase of 588,750 private units for $5,887,500, and non-managing sponsor investor expressions of interest in additional units and private units; $50,000/month administrative services fee and deferred $15,000/month payments to each of Charlton, Hammad and Schneck payable only upon a business combination; up to $350,000 in sponsor loan repayments and up to $1,500,000 of convertible working capital loans; audited financial statements as of December 31, 2025 showing no revenues and a net loss of $47,000 since inception; dilution tables showing immediate public-shareholder dilution of 28.9% assuming no over-allotment; sponsor lock-ups of six months for founder shares, 30 days for private units, and 180 days for securities under the underwriting agreement; and extensive conflict-of-interest, risk-factor and sponsor-compensation disclosure. The filing confirms the SPAC is pre-deal: no target selected, no substantive discussions, and the 24-month deadline is not a fixed date but runs from the IPO closing. Why it matters: This is the governing disclosure document for NHIV's proposed IPO and will set the trust-per-share value, redemption procedures, liquidation deadline, sponsor economics, dilution and investor protections from the moment the SPAC lists. It gives existing and prospective investors the mechanics they need to track redemption terms and the start of the 24-month completion window, and it confirms there is no pending business combination, extension vote or redemption event today. It is also the source for sponsor-conduct concerns: nominal-price founder shares, deferred success-only compensation, broad discretion to amend the sponsor letter agreement, anti-dilution founder-share conversion, and the sponsor's ability to make permitted purchases of public shares.
What changed: Amendment No. 1 to Registration Statement on Form S-1 (Preliminary Prospectus) for the initial public offering of NewHold Investment Corp IV, a blank check company (SPAC) seeking a business combination, primarily in industrial technology. This amendment updates the registration statement with audited financial statements as of December 31, 2025, and for the period from inception through that date, and includes the underwriting agreement and other exhibits. The prospectus remains subject to completion. Why it matters: Establishes the terms of a new SPAC IPO with a $175 million trust ($10.00 per share), a 24-month deadline (extendable by shareholder vote), and standard redemption rights. The sponsor purchased founder shares at a nominal price, creating a conflict of interest. The filing details the sponsor's compensation and lock-up arrangements. There is no target business identified yet.
What changed: Registration Statement (S-1) for the initial public offering of NewHold Investment Corp IV, a blank-check SPAC formed to pursue an initial business combination, primarily in industrial technology. This is the initial S-1 filing for a new SPAC, NHIV. The registration statement describes the terms of the IPO of 17,500,000 units at $10.00/unit, each unit consisting of one Class A ordinary share and one-third of a warrant. It details the sponsor's structure (NewHold Industrial Technology IV LLC, formed Aug. 2025), the 24-month deadline to consummate a business combination, the $175M trust deposit, redemption mechanics, and the extensive conflicts of interest related to the multiple prior NHIC SPACs and concurrent NHIC III. No prior S-1 exists for this issuer. Why it matters: This filing establishes all initial terms for a new SPAC by the NewHold group. While it initiates no redemption deadline or deal risk (the SPAC is pre-IPO), it is material for investors tracking sponsor conduct and terms. The filing discloses an unusually high degree of potential conflicts: the management team's roles at NHIC I (Evolv), the liquidated NHIC II, and the still-searching NHIC III create a 'queue' of potential targets. The non-managing sponsor investors' expression of interest in purchasing substantially all of the offering, combined with their indirect founder-share stake, raises governance concerns about a controlled company. The 24-month deadline (extendable with shareholder vote) and the $10.06 trust value are standard but set the baseline for all future monitoring.
What changed: A formal correspondence from the SEC Division of Corporation Finance, Office of Real Estate & Construction, advising NewHold Investment Corp IV that the agency does not intend to review its draft Registration Statement on Form S-1. The SEC staff acknowledged the draft S-1 submitted on December 8, 2025, but declined to examine it. The SEC directed the company to publicly file the registration statement and all nonpublic drafts at least 15 days prior to any road show as defined in Rule 433(h)(4) or, without a road show, 15 days before the requested effective date. The correspondence cited Rules 460 and 461 regarding acceleration requests and explicitly placed disclosure accuracy responsibility on the company and management. Why it matters: This notification does not alter investor redemption calendars or trust distributions. It confirms active capital markets activity by CEO Kevin Charlton while removing the typical SEC comment period, which compresses the timeline for any subsequent business combination filings or shareholder notice requirements. The document contains no substantive business claims; it offers no data on customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel movements beyond identifying contact person David Link (202-551-3356) and copying Terry Bokosha.
What changed: A draft registration statement on Form S-1 filed confidentially by NewHold Investment Corp IV, a blank-check SPAC seeking to raise $175,000,000 in an initial public offering of 17,500,000 units at $10.00 per unit. No change to a previously effective filing; this is the initial confidential filing of the IPO registration statement. Key terms: trust deposit of $10.00 per unit ($175M); 24-month deadline to complete a business combination; sponsor paid $25,000 for 6,708,333 founder shares ($0.004/share); sponsor and BTIG commit to purchase 584,300 private units ($5.843M); target enterprise value of $700M+ in industrial technology; no target selected. Why it matters: This filing establishes the baseline terms for NHIV's IPO. Investors can track trust value of $10.06 vs. the $10.00 deposit; note the 24-month deadline (approx. April 2028); the sponsor's nominal cost creating dilution risk; and the explicit statement that no target has been selected. The filing also details redemption mechanics, extension provisions, and conflict-of-interest disclosures that investors should monitor.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.